Why Is Protein–Energy Wasting Associated With Mortality in Chronic Kidney Disease?
To access this article, please choose from the options below
The authors were supported by a research grant (R01 DK078106) from the National Institutes of Diabetes, Digestive and Kidney Disease of the National Institutes of Health. Dr. Kalantar-Zadeh has received grants or honoraria from NovoNordisk, the manufacturer of growth hormone; Abbott, the manufacturer of Nepro and Oxepa; and Nutripletion, the manufacturer of intradialytic parenteral nutrition. Dr. Kovesdy has no conflicts of interest to declare.
PII: S0270-9295(08)00165-4
doi:10.1016/j.semnephrol.2008.10.002
© 2009 Elsevier Inc. All rights reserved.
